HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical remission of Merkel cell carcinoma after treatment with imatinib.

AuthorsDagmara Ewa Loader, Robert Feldmann, Magdalena Baumgartner, Friedrich Breier, David Schrama, Jürgen Christian Becker, Andreas Steiner
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 69 Issue 4 Pg. e181-3 (Oct 2013) ISSN: 1097-6787 [Electronic] United States
PMID24034390 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Aged, 80 and over
  • Antineoplastic Agents (therapeutic use)
  • Benzamides (therapeutic use)
  • Biopsy, Needle
  • Carcinoma, Merkel Cell (diagnosis, drug therapy)
  • Cheek
  • Fatal Outcome
  • Female
  • Humans
  • Imatinib Mesylate
  • Immunohistochemistry
  • Magnetic Resonance Imaging (methods)
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Staging
  • Piperazines (therapeutic use)
  • Pyrimidines (therapeutic use)
  • Skin Neoplasms (diagnosis, drug therapy)
  • Subcutaneous Tissue (pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: